We respond to NHS England breast cancer waiting times: September 2020 and Q2 20/21

NHS England cancer waiting times data from September 2020 shows: The two week wait target for people referred with suspected breast cancer was...

12 November 2020

We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT

Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said: While we’ve known for some time that HRT increases the risk of breast...

10 November 2020

We respond to news that the pandemic ‘threatens research as early career scientists look to leave’

Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said, It’s is deeply concerning that 40% of charity-funded early career...

10 November 2020

We support recommendations for faster and wider access to innovative cancer treatments

Mia Rosenblatt, Associate Director of Policy and Influencing at Breast Cancer Now, said: “We are very concerned that often there can be...

9 November 2020

We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS

The Scottish Medicines Consortium (SMC) has today (9 November 2020) approved: Trastuzumab emtansine (Kadcyla) for routine NHS use in Scotland...

9 November 2020

We respond to the launch of the NHS’s Help Us Help You access campaign

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It is cause for great concern that almost half (48%) of the people...

9 October 2020

We respond to NHS England breast cancer waiting times: August 2020

NHS England cancer waiting times data from August 2020 shows: The two week wait target for people referred with suspected breast cancer was not...

8 October 2020

We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to range of precision treatments

The plasmaMATCH trial which investigates whether simple blood tests known as ‘liquid biopsies’ can benefit women with breast cancer by tracking...

11 September 2020

We respond to study suggesting that 'lack of oxygen in tumors promotes metastasis'

A study from the University of Basal has suggested that lack of oxygen supply to a cancer tumour might encourage cells to break away from the primary...

9 September 2020